To adapt to this new world we find ourselves living in, we have taken our printed magazine Forward online so we can continue to celebrate the best of innovation and exploration with you. Forward now brings you the same latest News & Insights from the world of IP as before, as well as in depth Forward: Features looking at the most compelling developments taking place in the scientific and entrepreneurial worlds. The best of both are sent out in our monthly email round-up. Subscribe below.
Forward: News & Insights brings you the latest from the world of IP including hot topics, new and exciting technologies and innovations together with IP law and practice updates.
Nick Sutcliffe - Oct 21, 2020
The treatment of cancer patients with therapies that are specifically targeted to their cancer is a major goal of precision medicine and may lead to significantly improved clinical outcomes.
Sign up to Mewburn Ellis Forward. Our monthly newsletter sharing the latest news, insights and features from the world of IP.
As we move towards a circular economy, there is a huge incentive for..
Minimising person to person contact is the major weapon in reducing..
As explained in our article “Mixed reality: Is it the blend that will..
Patent Box legislation has been very much in vogue over the last few..
Extended reality (XR) is an umbrella term covering technologies that..
In 2012, Jennifer Doudna and Emmanuelle Charpentier published their ..
Many of us will know someone who has undergone a biopsy during a..
Imagine the following situation: you just received your brand-new,..
Forward: Features celebrate the best of innovation and exploration. These independent articles aim to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial worlds.
From simulating the evaluation of cardiovascular patients to turning CT scans into 3D holograms, Forward explores mixed reality and its increasingly innovative use in medicine.
Forward: features are independent pieces written for Mewburn Ellis discussing and celebrating the best of innovation...
As part of our Thought Leaders series, Mewburn Ellis Partner Sam..
Forward: features discuss and celebrate the best of innovation and..
Forward editor Caitlin Mackesy Davies finds out why one of our best..
Inspired by muscles and activated by light, this lifelike and..
Compelling advancements in cellular science could soon see us..
As part of our Thought Leaders series, Mewburn Ellis Senior Associate..
Spectromics is working to put our existing arsenal of antibiotics to..
It may be a bother for sunbathers, but seaweed is a promising..
Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.
Sign up to Forward: news, insights and features from Mewburn Ellis
Copyright © 2020 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy